![](/img/cover-not-exists.png)
Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC
Joode, K.D., Groen, H.J.M., Van der Veldt, A.A.M., Suijkerbuijk, K.P.M., de Groot, J.W.B., de Wijn, R., Hurkmans, D.P., van den Heuvel, D.M.A., Schmidt, K., Groten, J.P., Verdegaal, E.M.E., van der BuVolume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.094
Date:
September, 2020
File:
PDF, 75 KB
2020